Submitted by Anonymous (not verified) on 22 September 2023 - 14:38
Human medicines European public assessment report (EPAR): Alunbrig, brigatinib, Carcinoma, Non-Small-Cell Lung, Date of authorisation: 22/11/2018, Revision: 9, Status: Authorised
Source: